Physician profile
Christopher Miller
NPI 1083975452
$1,455.93
in general payments reported to CMS, 2019-2025
16 companies · $327 in 2025
The $327 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $109 · 2021: $220 · 2022: $162 · 2023: $145 · 2024: $313 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $496.29 | 2019-2024 | Dyanavel Xr |
| Corium, LLC | $223.90 | 2023-2025 | Azstarys |
| Pfizer INC. | $199.21 | 2019-2025 | |
| Glaxosmithkline, LLC. | $109.58 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Genzyme Corporation | $77.66 | 2023-2025 | |
| Sanofi Pasteur INC. | $45.28 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $45.26 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $41.66 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $38.62 | 2022-2024 | |
| Cranial Technologies, INC | $36.82 | 2022-2024 | Doc Band |
| Adlon Therapeutics L.P. | $31.55 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $23.98 | 2024 | Flumist Quadrivalent |
| Novo Nordisk INC | $23.95 | 2021 | |
| Merck Sharp & Dohme LLC | $20.42 | 2025 | Gardasil 9 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $16.28 | 2023 | Odactra, Ragwitek, Grastek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.